Literature DB >> 22665238

Analytical methods for disease association studies with immunogenetic data.

Jill A Hollenbach1, Steven J Mack, Glenys Thomson, Pierre-Antoine Gourraud.   

Abstract

Disease association studies involving highly polymorphic immunogenetic data may involve analyses at one or many units of analysis, including amino acid, allele, genotype and haplotype levels, as well as consideration of gene-gene or gene-environment interactions. The selection of the appropriate statistical tests is critical and will be dependent on the nature of the dataset (e.g., case-control vs. family data) as well as the specific research hypotheses being tested. This paper describes the various study and analysis categories used for such analyses, including the advantages and limitations of such techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665238      PMCID: PMC4209949          DOI: 10.1007/978-1-61779-842-9_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  46 in total

1.  Natural killer cells fertile with receptors for HLA-G?

Authors:  L L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Signatures of demographic history and natural selection in the human major histocompatibility complex Loci.

Authors:  Diogo Meyer; Richard M Single; Steven J Mack; Henry A Erlich; Glenys Thomson
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

3.  Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions.

Authors:  S J Mack; T L Bugawan; P V Moonsamy; J A Erlich; E A Trachtenberg; Y K Paik; A B Begovich; N Saha; H P Beck; M Stoneking; H A Erlich
Journal:  Tissue Antigens       Date:  2000-05

Review 4.  Hanging in the balance. KIR and their role in disease.

Authors:  Anthony P Williams; Andrew R Bateman; Salim I Khakoo
Journal:  Mol Interv       Date:  2005-08

5.  Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects.

Authors:  Jill A Hollenbach; Susan D Thompson; Teodorica L Bugawan; Mary Ryan; Marc Sudman; Miranda Marion; Carl D Langefeld; Glenys Thomson; Henry A Erlich; David N Glass
Journal:  Arthritis Rheum       Date:  2010-06

6.  Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.

Authors:  J Y Sun; L Gaidulis; A Dagis; J Palmer; R Rodriguez; M M Miller; S J Forman; D Senitzer
Journal:  Bone Marrow Transplant       Date:  2005-09       Impact factor: 5.483

Review 7.  Non-HLA region genes in insulin dependent diabetes mellitus.

Authors:  L L Field
Journal:  Baillieres Clin Endocrinol Metab       Date:  1991-09

8.  HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II.

Authors:  Mary S Leffell; M Daniele Fallin; Henry A Erlich; Marcelo Fernandez-Vĩna; William H Hildebrand; Steven J Mack; Andrea A Zachary
Journal:  Hum Immunol       Date:  2002-07       Impact factor: 2.850

9.  KIR/HLA ligand incompatibility in kidney transplantation.

Authors:  Kristina Kunert; Marleen Seiler; Mir Farzin Mashreghi; Katrin Klippert; Constanze Schönemann; Konrad Neumann; Johann Pratschke; Petra Reinke; Hans-Dieter Volk; Katja Kotsch
Journal:  Transplantation       Date:  2007-12-15       Impact factor: 4.939

10.  HLA haplotypes in Singapore: a study of mothers and their cord blood units.

Authors:  Ting F Tang; Lihua Hou; Minghua Chen; Ian Belle; Steven Mack; Alex Lancaster; Grace Y H Ho; William Y K Hwang; Fidah Alsagoff; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Hum Immunol       Date:  2007-02-16       Impact factor: 2.850

View more
  13 in total

1.  Distribution of MICB diversity in the Zhejiang Han population: PCR sequence-based typing for exons 2-6 and identification of five novel MICB alleles.

Authors:  Yanling Ying; Yanmin He; Sudan Tao; Zhedong Han; Wei Wang; Nanying Chen; Junjun He; Wei Zhang; Ji He; Faming Zhu; Hangjun Lv
Journal:  Immunogenetics       Date:  2013-04-03       Impact factor: 2.846

2.  Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan.

Authors:  Asher Fawwad; Denira Govender; Mohammad Yakoob Ahmedani; Abdul Basit; Julie Ann Lane; Steven John Mack; Mark Alvin Atkinson; Clive Henry Wasserfall; Graham David Ogle; Janelle Annette Noble
Journal:  Diabetes Res Clin Pract       Date:  2019-01-30       Impact factor: 5.602

3.  HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.

Authors:  Hanna M Ollila; Jean-Marie Ravel; Fang Han; Juliette Faraco; Ling Lin; Xiuwen Zheng; Giuseppe Plazzi; Yves Dauvilliers; Fabio Pizza; Seung-Chul Hong; Poul Jennum; Stine Knudsen; Birgitte R Kornum; Xiao Song Dong; Han Yan; Heeseung Hong; Cristin Coquillard; Joshua Mahlios; Otto Jolanki; Mali Einen; Isabelle Arnulf; Sophie Lavault; Birgit Högl; Birgit Frauscher; Catherine Crowe; Markku Partinen; Yu Shu Huang; Patrice Bourgin; Outi Vaarala; Alex Désautels; Jacques Montplaisir; Steven J Mack; Michael Mindrinos; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  Am J Hum Genet       Date:  2015-01-08       Impact factor: 11.025

4.  Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline.

Authors:  Jill A Hollenbach; Steven J Mack; Derek J Pappas; Wesley Marin
Journal:  Hum Immunol       Date:  2015-12-18       Impact factor: 2.850

5.  Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Sudan.

Authors:  Tomader Ali Mohammed Ibrahim; Denira Govender; Mohamed Ahmed Abdullah; Janelle Annette Noble; Mohammed Osman Hussien; Julie Ann Lane; Steven John Mack; Gregory George Noble Martin; Mark Alvin Atkinson; Clive Henry Wasserfall; Graham David Ogle
Journal:  Pediatr Diabetes       Date:  2021-04-20       Impact factor: 3.409

6.  Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic.

Authors:  Fang Han; Juliette Faraco; Xiao Song Dong; Hanna M Ollila; Ling Lin; Jing Li; Pei An; Shan Wang; Ke Wei Jiang; Zhan Cheng Gao; Long Zhao; Han Yan; Ya Nan Liu; Qing Hua Li; Xiao Zhe Zhang; Yan Hu; Jing Yu Wang; Yun Hui Lu; Chang Jun Lu; Wei Zhou; Joachim Hallmayer; Yu Shu Huang; Kingman P Strohl; Thomas Pollmächer; Emmanuel Mignot
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

7.  The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.

Authors:  J A Hollenbach; M J Pando; S J Caillier; P-A Gourraud; J R Oksenberg
Journal:  Genes Immun       Date:  2016-02-11       Impact factor: 2.676

8.  Genome-wide association study of self-reported food reactions in Japanese identifies shrimp and peach specific loci in the HLA-DR/DQ gene region.

Authors:  Seik-Soon Khor; Ryoko Morino; Kazuyuki Nakazono; Shigeo Kamitsuji; Masanori Akita; Maiko Kawajiri; Tatsuya Yamasaki; Azusa Kami; Yuria Hoshi; Asami Tada; Kenichi Ishikawa; Maaya Hine; Miki Kobayashi; Nami Kurume; Naoyuki Kamatani; Katsushi Tokunaga; Todd A Johnson
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

9.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Authors:  Natasha Z R Steele; Jessie S Carr; Luke W Bonham; Ethan G Geier; Vincent Damotte; Zachary A Miller; Rahul S Desikan; Kevin L Boehme; Shubhabrata Mukherjee; Paul K Crane; John S K Kauwe; Joel H Kramer; Bruce L Miller; Giovanni Coppola; Jill A Hollenbach; Yadong Huang; Jennifer S Yokoyama
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

10.  High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Authors:  Steven J Mack; Julia Udell; Franziska Cohen; Kazutoyo Osoegawa; Sharon K Hawbecker; David A Noonan; Martha B Ladner; Damian Goodridge; Elizabeth A Trachtenberg; Jorge R Oksenberg; Henry A Erlich
Journal:  Genes Immun       Date:  2018-01-08       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.